Your browser is no longer supported. Please, upgrade your browser.
Settings
STAA STAAR Surgical Company daily Stock Chart
STAA [NASD]
STAAR Surgical Company
Index- P/E340.32 EPS (ttm)0.16 Insider Own0.90% Shs Outstand45.35M Perf Week-1.93%
Market Cap2.41B Forward P/E116.39 EPS next Y0.46 Insider Trans-59.90% Shs Float45.25M Perf Month12.73%
Income7.50M PEG11.34 EPS next Q0.04 Inst Own95.80% Short Float5.87% Perf Quarter-10.40%
Sales148.30M P/S16.28 EPS this Y172.90% Inst Trans-0.71% Short Ratio3.64 Perf Half Y63.83%
Book/sh3.85 P/B13.97 EPS next Y862.50% ROA3.60% Target Price66.80 Perf Year91.08%
Cash/sh2.59 P/C20.75 EPS next 5Y30.00% ROE4.60% 52W Range23.20 - 62.51 Perf YTD52.89%
Dividend- P/FCF652.36 EPS past 5Y27.40% ROI7.90% 52W High-13.98% Beta1.33
Dividend %- Quick Ratio5.20 Sales past 5Y14.90% Gross Margin72.20% 52W Low131.77% ATR2.19
Employees550 Current Ratio5.80 Sales Q/Q-11.30% Oper. Margin2.40% RSI (14)53.49 Volatility3.50% 4.42%
OptionableYes Debt/Eq0.01 EPS Q/Q-130.90% Profit Margin5.00% Rel Volume0.66 Prev Close54.30
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout0.00% Avg Volume730.64K Price53.77
Recom1.40 SMA204.31% SMA501.78% SMA20027.70% Volume478,712 Change-0.98%
Aug-31-20Upgrade Sidoti Neutral → Buy $58
Aug-06-20Reiterated The Benchmark Company Buy $50 → $66
Jul-06-20Downgrade Sidoti Buy → Neutral $58
Jun-24-20Downgrade BTIG Research Buy → Neutral
Jun-15-20Initiated Jefferies Buy $55
Dec-04-19Initiated BTIG Research Buy
Sep-24-18Reiterated The Benchmark Company Buy $45 → $54
Aug-06-18Resumed The Benchmark Company Buy $45
Nov-20-17Reiterated The Benchmark Company Buy $21
Aug-14-17Reiterated The Benchmark Company Buy $12 → $13
Mar-03-17Reiterated The Benchmark Company Buy $10 → $12
May-18-16Upgrade The Benchmark Company Hold → Buy $6
Sep-10-13Resumed The Benchmark Company Buy $15
Feb-28-13Reiterated The Benchmark Company Buy $10 → $6.50
Nov-01-12Downgrade Canaccord Genuity Buy → Hold $8.25 → $7
Mar-02-12Initiated Northland Securities Outperform $14
Oct-25-11Reiterated The Benchmark Company Buy $10 → $12.50
Oct-12-10Initiated Morgan Joseph Buy $6.40
May-11-10Initiated Benchmark Buy $7
Aug-17-09Reiterated MDB Capital Group Buy $3.25 → $5
Sep-24-20 04:10PM  
03:15PM  
03:00PM  
01:45PM  
01:00PM  
06:20AM  
Sep-23-20 11:45PM  
10:35PM  
03:30PM  
03:00PM  
02:45PM  
02:25PM  
01:11PM  
12:30PM  
12:30PM  
11:44AM  
Sep-22-20 09:32PM  
08:05PM  
03:59PM  
11:30AM  
10:01AM  
10:00AM  
09:12AM  
08:00AM  
06:20AM  
Sep-21-20 09:15PM  
06:26PM  
04:55PM  
03:43PM  
01:45PM  
01:35PM  
12:30PM  
11:05AM  
09:47AM  
Sep-20-20 10:25AM  
Sep-19-20 08:25PM  
05:15PM  
Sep-18-20 05:10PM  
04:25PM  
02:00PM  
01:20PM  
12:45PM  
12:15PM  
Sep-17-20 06:53PM  
05:10PM  
10:30AM  
09:52AM  
Sep-16-20 10:11PM  
08:45PM  
06:42PM  
05:04PM  
03:50PM  
03:45PM  
03:00PM  
01:45PM  
01:00PM  
12:00PM  
10:28AM  
09:47AM  
Sep-15-20 04:25PM  
02:55PM  
02:45PM  
02:00PM  
12:30PM  
11:36AM  
09:39AM  
Sep-14-20 07:10PM  
03:10PM  
01:25PM  
01:04PM  
01:00PM  
11:30AM  
09:27AM  
08:00AM  
07:00AM  
06:20AM  
Sep-12-20 01:15PM  
Sep-11-20 02:45PM  
01:10PM  
06:20AM  
Sep-10-20 10:30PM  
07:30PM  
05:55PM  
04:50PM  
04:23PM  
03:56PM  
02:45PM  
02:00PM  
11:30AM  
11:00AM  
Sep-09-20 05:30PM  
05:00PM  
02:45PM  
02:00PM  
11:40AM  
11:00AM  
06:31AM  
Sep-08-20 11:50PM  
10:30PM  
09:25PM  
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holliday KeithChief Technology OfficerSep 15Option Exercise27.0436,326982,42455,658Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 15Sale53.3336,3261,937,26619,332Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Option Exercise10.2426,574272,20855,021Sep 16 06:01 PM
Holliday KeithChief Technology OfficerSep 14Sale53.3235,6891,902,89319,332Sep 16 06:01 PM
Moore John CDirectorSep 09Sale52.04137,3317,146,70521,387Sep 11 04:07 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Option Exercise10.1841,602423,69752,396Aug 12 06:30 PM
Hayashida Jon K.VP, Global Clinical, MedicalAug 10Sale51.2241,6022,130,85410,794Aug 12 06:30 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Option Exercise8.1139,215318,165167,165Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 15Sale44.0739,2151,728,205127,950Jun 17 05:03 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Option Exercise11.007858,635128,735Jun 12 04:01 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaJun 10Sale44.0078534,540127,950Jun 12 04:01 PM
Gesten Samuel JChief Legal OfficerMay 21Sale40.00192,5227,700,88041,185May 26 04:16 PM
Holliday KeithChief Technology OfficerMay 15Option Exercise7.2025,000180,00053,447May 15 06:10 PM
Holliday KeithChief Technology OfficerMay 15Sale37.6925,000942,25028,447May 15 06:10 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 13Option Exercise5.346,66735,60251,133May 13 06:49 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Option Exercise13.6620,283277,01929,972May 13 06:48 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Option Exercise12.0718,856227,50263,322May 13 06:49 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Option Exercise8.4846,563394,87957,357May 13 06:50 PM
Hayashida Jon K.VP, Global Clinical, MedicalMay 11Sale39.1146,5631,821,07910,794May 13 06:50 PM
Francese James ESr. VP, Comm. Ops., NA, APACMay 11Sale39.0618,856736,51544,466May 13 06:49 PM
Hansen Graydon C.Sr. VP, Global OperationsMay 11Sale39.0218,189709,70816,022May 13 06:48 PM
Hayashida Jon K.VP, Global Clinical, MedicalMar 23Sale26.832,81375,47310,794Mar 24 04:18 PM
Hansen Graydon C.Sr. VP, Global OperationsMar 23Sale27.422,81377,13219,459Mar 24 04:16 PM
Gesten Samuel JChief Legal OfficerMar 23Sale27.422,74275,18641,185Mar 24 04:14 PM
Francese James ESr. VP, Comm. Ops., NA, APACMar 23Sale26.772,25060,23344,466Mar 24 04:13 PM
ANDREWS DEBORAH JChief Financial OfficerMar 23Sale27.4283422,86831,267Mar 24 04:09 PM
Moore John CDirectorMar 18Option Exercise5.8110,00058,10066,422Mar 19 04:15 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Option Exercise11.11106,6041,184,228138,705Jan 23 04:06 PM
ANDREWS DEBORAH JChief Financial OfficerJan 21Sale42.20106,6044,498,68932,101Jan 23 04:06 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Option Exercise8.6432,335279,37453,658Dec 06 04:35 PM
Hayashida Jon K.VP, Global Clinical, MedicalDec 05Sale37.2047,4081,763,6196,250Dec 06 04:35 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Option Exercise5.6045,000251,800149,200Dec 06 04:34 PM
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, ChinaDec 04Sale38.1545,0001,716,750124,200Dec 06 04:34 PM
Moore John CDirectorNov 25Option Exercise4.7320,00094,60065,035Nov 26 04:33 PM
Hansen Graydon C.Sr. VP, Global OperationsNov 22Option Exercise8.6813,938120,96922,272Nov 22 04:59 PM
Hansen Graydon C.Sr. VP, Global OperationsNov 20Sale35.0217,083598,2478,334Nov 22 04:59 PM
ANDREWS DEBORAH JChief Financial OfficerNov 14Sale34.684,167144,51232,101Nov 15 04:15 PM
Barnes Scott DChief Medical OfficerNov 14Sale34.931,58355,29411,032Nov 15 04:12 PM
Holliday KeithChief Technology OfficerNov 05Sale35.0014,441505,43514,323Nov 06 04:26 PM
Holliday KeithChief Technology OfficerNov 04Sale35.002,10073,50028,764Nov 06 04:26 PM